-
1
-
-
13344285339
-
Identification and characterization of a new member of the TNF family that induces apoptosis
-
1. SR Wiley K Schooley PJ Smolak 1995 Identification and characterization of a new member of the TNF family that induces apoptosis Immunity 3 673 682 8777713 10.1016/1074-7613(95)90057-8 1:CAS:528:DyaK28XhtF2iug%3D%3D Wiley SR, Schooley K, Smolak PJ et al (1995) Identification and characterization of a new member of the TNF family that induces apoptosis. Immunity 3:673–682
-
(1995)
Immunity
, vol.3
, pp. 673-682
-
-
Wiley, SR1
Schooley, K2
Smolak, PJ3
-
2
-
-
0034630161
-
The CD95 (APO-1/Fas) and the TRAIL (APO-2L) apoptosis systems
-
2. H Walczak PH Krammer 2000 The CD95 (APO-1/Fas) and the TRAIL (APO-2L) apoptosis systems Exp Cell Res 256 58 66 10739652 10.1006/excr.2000.4840 1:CAS:528:DC%2BD3cXitVajsb4%3D Walczak H, Krammer PH (2000) The CD95 (APO-1/Fas) and the TRAIL (APO-2L) apoptosis systems. Exp Cell Res 256:58–66
-
(2000)
Exp Cell Res
, vol.256
, pp. 58-66
-
-
Walczak, H1
Krammer, PH2
-
3
-
-
0032713075
-
Safety and antitumor activity of recombinant soluble Apo2 ligand
-
3. A Ashkenazi RC Pai S Fong 1999 Safety and antitumor activity of recombinant soluble Apo2 ligand J Clin Invest 104 155 162 10411544 10.1172/JCI6926 1:CAS:528:DyaK1MXkslSmsbw%3D Ashkenazi A, Pai RC, Fong S et al (1999) Safety and antitumor activity of recombinant soluble Apo2 ligand. J Clin Invest 104:155–162
-
(1999)
J Clin Invest
, vol.104
, pp. 155-162
-
-
Ashkenazi, A1
Pai, RC2
Fong, S3
-
4
-
-
0032929520
-
Tumoricidal activity of tumor necrosis factor-related apoptosis-inducing ligand in vivo
-
4. H Walczak RE Miller K Ariail 1999 Tumoricidal activity of tumor necrosis factor-related apoptosis-inducing ligand in vivo Nat Med 5 157 163 9930862 10.1038/5517 1:CAS:528:DyaK1MXntlSrug%3D%3D Walczak H, Miller RE, Ariail K et al (1999) Tumoricidal activity of tumor necrosis factor-related apoptosis-inducing ligand in vivo. Nat Med 5:157–163
-
(1999)
Nat Med
, vol.5
, pp. 157-163
-
-
Walczak, H1
Miller, RE2
Ariail, K3
-
5
-
-
0030996297
-
The receptor for the cytotoxic ligand TRAIL
-
5. G Pan K O’Rourke AM Chinnaiyan 1997 The receptor for the cytotoxic ligand TRAIL Science 276 111 113 9082980 10.1126/science.276.5309.111 1:CAS:528:DyaK2sXitl2jsL4%3D Pan G, O’Rourke K, Chinnaiyan AM et al (1997) The receptor for the cytotoxic ligand TRAIL. Science 276:111–113
-
(1997)
Science
, vol.276
, pp. 111-113
-
-
Pan, G1
O’Rourke, K2
Chinnaiyan, AM3
-
6
-
-
0030880548
-
TRAIL-R2: a novel apoptosis-mediating receptor for TRAIL
-
6. H Walczak MA Degli-Esposti RS Johnson 1997 TRAIL-R2: a novel apoptosis-mediating receptor for TRAIL Embo J 16 5386 5397 9311998 10.1093/emboj/16.17.5386 1:CAS:528:DyaK2sXmsVGlsLo%3D Walczak H, Degli-Esposti MA, Johnson RS et al (1997) TRAIL-R2: a novel apoptosis-mediating receptor for TRAIL. Embo J 16:5386–5397
-
(1997)
Embo J
, vol.16
, pp. 5386-5397
-
-
Walczak, H1
Degli-Esposti, MA2
Johnson, RS3
-
7
-
-
0030869432
-
Cloning and characterization of TRAIL-R3, a novel member of the emerging TRAIL receptor family
-
7. MA Degli-Esposti PJ Smolak H Walczak 1997 Cloning and characterization of TRAIL-R3, a novel member of the emerging TRAIL receptor family J Exp Med 186 1165 1170 9314565 10.1084/jem.186.7.1165 1:CAS:528:DyaK2sXmsFaqs70%3D Degli-Esposti MA, Smolak PJ, Walczak H et al (1997) Cloning and characterization of TRAIL-R3, a novel member of the emerging TRAIL receptor family. J Exp Med 186:1165–1170
-
(1997)
J Exp Med
, vol.186
, pp. 1165-1170
-
-
Degli-Esposti, MA1
Smolak, PJ2
Walczak, H3
-
8
-
-
0031414749
-
The novel receptor TRAIL-R4 induces NF-kappaB and protects against TRAIL-mediated apoptosis, yet retains an incomplete death domain
-
8. MA Degli-Esposti WC Dougall PJ Smolak 1997 The novel receptor TRAIL-R4 induces NF-kappaB and protects against TRAIL-mediated apoptosis, yet retains an incomplete death domain Immunity 7 813 820 9430226 10.1016/S1074-7613(00)80399-4 1:CAS:528:DyaK1cXjsFWgtQ%3D%3D Degli-Esposti MA, Dougall WC, Smolak PJ et al (1997) The novel receptor TRAIL-R4 induces NF-kappaB and protects against TRAIL-mediated apoptosis, yet retains an incomplete death domain. Immunity 7:813–820
-
(1997)
Immunity
, vol.7
, pp. 813-820
-
-
Degli-Esposti, MA1
Dougall, WC2
Smolak, PJ3
-
9
-
-
7344233085
-
Osteoprotegerin is a receptor for the cytotoxic ligand TRAIL
-
9. JG Emery P McDonnell MB Burke 1998 Osteoprotegerin is a receptor for the cytotoxic ligand TRAIL J Biol Chem 273 14363 14367 9603945 10.1074/jbc.273.23.14363 1:CAS:528:DyaK1cXjs1Oru70%3D Emery JG, McDonnell P, Burke MB et al (1998) Osteoprotegerin is a receptor for the cytotoxic ligand TRAIL. J Biol Chem 273:14363–14367
-
(1998)
J Biol Chem
, vol.273
, pp. 14363-14367
-
-
Emery, JG1
McDonnell, P2
Burke, MB3
-
10
-
-
33845872311
-
Following the TRAIL to apoptosis
-
10. BR Chaudhari RF Murphy DK Agrawal 2006 Following the TRAIL to apoptosis Immunol Res 35 249 262 17172650 10.1385/IR:35:3:249 1:CAS:528:DC%2BD28Xht1OjsbnF Chaudhari BR, Murphy RF, Agrawal DK (2006) Following the TRAIL to apoptosis. Immunol Res 35:249–262
-
(2006)
Immunol Res
, vol.35
, pp. 249-262
-
-
Chaudhari, BR1
Murphy, RF2
Agrawal, DK3
-
11
-
-
0027275490
-
A novel domain within the 55 kd TNF receptor signals cell death
-
11. LA Tartaglia TM Ayres GH Wong DV Goeddel 1993 A novel domain within the 55 kd TNF receptor signals cell death Cell 74 845 853 8397073 10.1016/0092-8674(93)90464-2 1:CAS:528:DyaK2cXhvV2gsrc%3D Tartaglia LA, Ayres TM, Wong GH, Goeddel DV (1993) A novel domain within the 55 kd TNF receptor signals cell death. Cell 74:845–853
-
(1993)
Cell
, vol.74
, pp. 845-853
-
-
Tartaglia, LA1
Ayres, TM2
Wong, GH3
Goeddel, DV4
-
12
-
-
0028883850
-
Cytotoxicity-dependent APO-1 (Fas/CD95)-associated proteins form a death-inducing signaling complex (DISC) with the receptor
-
12. FC Kischkel S Hellbardt I Behrmann 1995 Cytotoxicity-dependent APO-1 (Fas/CD95)-associated proteins form a death-inducing signaling complex (DISC) with the receptor Embo J 14 5579 5588 8521815 1:CAS:528:DyaK2MXpslamtr4%3D Kischkel FC, Hellbardt S, Behrmann I et al (1995) Cytotoxicity-dependent APO-1 (Fas/CD95)-associated proteins form a death-inducing signaling complex (DISC) with the receptor. Embo J 14:5579–5588
-
(1995)
Embo J
, vol.14
, pp. 5579-5588
-
-
Kischkel, FC1
Hellbardt, S2
Behrmann, I3
-
13
-
-
0033667778
-
FADD/MORT1 and caspase-8 are recruited to TRAIL receptors 1 and 2 and are essential for apoptosis mediated by TRAIL receptor 2
-
13. MR Sprick MA Weigand E Rieser 2000 FADD/MORT1 and caspase-8 are recruited to TRAIL receptors 1 and 2 and are essential for apoptosis mediated by TRAIL receptor 2 Immunity 12 599 609 10894160 10.1016/S1074-7613(00)80211-3 1:CAS:528:DC%2BD3cXkslagtb8%3D Sprick MR, Weigand MA, Rieser E et al (2000) FADD/MORT1 and caspase-8 are recruited to TRAIL receptors 1 and 2 and are essential for apoptosis mediated by TRAIL receptor 2. Immunity 12:599–609
-
(2000)
Immunity
, vol.12
, pp. 599-609
-
-
Sprick, MR1
Weigand, MA2
Rieser, E3
-
14
-
-
0033613143
-
Caspase activation: the induced-proximity model
-
14. GS Salvesen VM Dixit 1999 Caspase activation: the induced-proximity model Proc Natl Acad Sci USA 96 10964 10967 10500109 10.1073/pnas.96.20.10964 1:CAS:528:DyaK1MXmvVCnt7k%3D Salvesen GS, Dixit VM (1999) Caspase activation: the induced-proximity model. Proc Natl Acad Sci USA 96:10964–10967
-
(1999)
Proc Natl Acad Sci USA
, vol.96
, pp. 10964-10967
-
-
Salvesen, GS1
Dixit, VM2
-
15
-
-
0042303323
-
The CD95 type I/type II model
-
15. BC Barnhart EC Alappat ME Peter 2003 The CD95 type I/type II model Semin Immunol 15 185 193 14563117 10.1016/S1044-5323(03)00031-9 1:CAS:528:DC%2BD3sXmsl2rtb8%3D Barnhart BC, Alappat EC, Peter ME (2003) The CD95 type I/type II model. Semin Immunol 15:185–193
-
(2003)
Semin Immunol
, vol.15
, pp. 185-193
-
-
Barnhart, BC1
Alappat, EC2
Peter, ME3
-
16
-
-
0032555716
-
Bid, a Bcl2 interacting protein, mediates cytochrome c release from mitochondria in response to activation of cell surface death receptors
-
16. X Luo I Budihardjo H Zou 1998 Bid, a Bcl2 interacting protein, mediates cytochrome c release from mitochondria in response to activation of cell surface death receptors Cell 94 481 490 9727491 10.1016/S0092-8674(00)81589-5 1:CAS:528:DyaK1cXlslOrsbw%3D Luo X, Budihardjo I, Zou H et al (1998) Bid, a Bcl2 interacting protein, mediates cytochrome c release from mitochondria in response to activation of cell surface death receptors. Cell 94:481–490
-
(1998)
Cell
, vol.94
, pp. 481-490
-
-
Luo, X1
Budihardjo, I2
Zou, H3
-
17
-
-
3042743700
-
Regulation of TRAIL-induced apoptosis by ectopic expression of antiapoptotic factors
-
17. BB Aggarwal U Bhardwaj Y Takada 2004 Regulation of TRAIL-induced apoptosis by ectopic expression of antiapoptotic factors Vitam Horm 67 453 483 15110190 1:CAS:528:DC%2BD2cXltlKgtb8%3D Aggarwal BB, Bhardwaj U, Takada Y (2004) Regulation of TRAIL-induced apoptosis by ectopic expression of antiapoptotic factors. Vitam Horm 67:453–483
-
(2004)
Vitam Horm
, vol.67
, pp. 453-483
-
-
Aggarwal, BB1
Bhardwaj, U2
Takada, Y3
-
18
-
-
16644372319
-
Following a TRAIL: update on a ligand and its five receptors
-
18. FC Kimberley GR Screaton 2004 Following a TRAIL: update on a ligand and its five receptors Cell Res 14 359 372 15538968 10.1038/sj.cr.7290236 1:CAS:528:DC%2BD2MXhsFekt7g%3D Kimberley FC, Screaton GR (2004) Following a TRAIL: update on a ligand and its five receptors. Cell Res 14:359–372
-
(2004)
Cell Res
, vol.14
, pp. 359-372
-
-
Kimberley, FC1
Screaton, GR2
-
19
-
-
0000005230
-
Differential localization and regulation of death and decoy receptors for TNF-related apoptosis-inducing ligand (TRAIL) in human melanoma cells
-
19. XD Zhang AV Franco T Nguyen 2000 Differential localization and regulation of death and decoy receptors for TNF-related apoptosis-inducing ligand (TRAIL) in human melanoma cells J Immunol 164 3961 3970 10754286 1:CAS:528:DC%2BD3cXis1Wlur4%3D Zhang XD, Franco AV, Nguyen T et al (2000) Differential localization and regulation of death and decoy receptors for TNF-related apoptosis-inducing ligand (TRAIL) in human melanoma cells. J Immunol 164:3961–3970
-
(2000)
J Immunol
, vol.164
, pp. 3961-3970
-
-
Zhang, XD1
Franco, AV2
Nguyen, T3
-
20
-
-
0032500793
-
Cell surface trafficking of Fas: a rapid mechanism of p53-mediated apoptosis
-
20. M Bennett K Macdonald SW Chan 1998 Cell surface trafficking of Fas: a rapid mechanism of p53-mediated apoptosis Science 282 290 293 9765154 10.1126/science.282.5387.290 1:CAS:528:DyaK1cXmsF2ju70%3D Bennett M, Macdonald K, Chan SW et al (1998) Cell surface trafficking of Fas: a rapid mechanism of p53-mediated apoptosis. Science 282:290–293
-
(1998)
Science
, vol.282
, pp. 290-293
-
-
Bennett, M1
Macdonald, K2
Chan, SW3
-
21
-
-
0033555395
-
TNF recruits TRADD to the plasma membrane but not the trans-Golgi network, the principal subcellular location of TNF-R1
-
21. SJ Jones EC Ledgerwood JB Prins 1999 TNF recruits TRADD to the plasma membrane but not the trans-Golgi network, the principal subcellular location of TNF-R1 J Immunol 162 1042 1048 9916731 1:CAS:528:DyaK1MXovFyisg%3D%3D Jones SJ, Ledgerwood EC, Prins JB et al (1999) TNF recruits TRADD to the plasma membrane but not the trans-Golgi network, the principal subcellular location of TNF-R1. J Immunol 162:1042–1048
-
(1999)
J Immunol
, vol.162
, pp. 1042-1048
-
-
Jones, SJ1
Ledgerwood, EC2
Prins, JB3
-
22
-
-
0037103742
-
The p55 tumour necrosis factor receptor TNFR1 contains a trans-Golgi network localization signal in the C-terminal region of its cytoplasmic tail
-
22. H Storey A Stewart P Vandenabeele JP Luzio 2002 The p55 tumour necrosis factor receptor TNFR1 contains a trans-Golgi network localization signal in the C-terminal region of its cytoplasmic tail Biochem J 366 15 22 11985495 1:CAS:528:DC%2BD3sXptFOhsbk%3D Storey H, Stewart A, Vandenabeele P, Luzio JP (2002) The p55 tumour necrosis factor receptor TNFR1 contains a trans-Golgi network localization signal in the C-terminal region of its cytoplasmic tail. Biochem J 366:15–22
-
(2002)
Biochem J
, vol.366
, pp. 15-22
-
-
Storey, H1
Stewart, A2
Vandenabeele, P3
Luzio, JP4
-
23
-
-
30944448775
-
A BAR domain in the N terminus of the Arf GAP ASAP1 affects membrane structure and trafficking of epidermal growth factor receptor
-
23. Z Nie DS Hirsch R Luo 2006 A BAR domain in the N terminus of the Arf GAP ASAP1 affects membrane structure and trafficking of epidermal growth factor receptor Curr Biol 16 130 139 16431365 10.1016/j.cub.2005.11.069 1:CAS:528:DC%2BD28Xosl2msw%3D%3D Nie Z, Hirsch DS, Luo R et al (2006) A BAR domain in the N terminus of the Arf GAP ASAP1 affects membrane structure and trafficking of epidermal growth factor receptor. Curr Biol 16:130–139
-
(2006)
Curr Biol
, vol.16
, pp. 130-139
-
-
Nie, Z1
Hirsch, DS2
Luo, R3
-
24
-
-
85121088501
-
-
24. Randazzo PA, Nie Z, Miura K, Hsu VW (2000) Molecular aspects of the cellular activities of ADP-ribosylation factors. Sci STKE 2000:RE1
-
-
-
-
25
-
-
0346725004
-
Arf GAPs: multifunctional proteins that regulate membrane traffic and actin remodelling
-
25. PA Randazzo DS Hirsch 2004 Arf GAPs: multifunctional proteins that regulate membrane traffic and actin remodelling Cell Signal 16 401 413 14709330 10.1016/j.cellsig.2003.09.012 1:CAS:528:DC%2BD2cXptVGr Randazzo PA, Hirsch DS (2004) Arf GAPs: multifunctional proteins that regulate membrane traffic and actin remodelling. Cell Signal 16:401–413
-
(2004)
Cell Signal
, vol.16
, pp. 401-413
-
-
Randazzo, PA1
Hirsch, DS2
-
26
-
-
7744230736
-
ACAP1 promotes endocytic recycling by recognizing recycling sorting signals
-
26. J Dai J Li E Bos 2004 ACAP1 promotes endocytic recycling by recognizing recycling sorting signals Dev Cell 7 771 776 15525538 10.1016/j.devcel.2004.10.002 1:CAS:528:DC%2BD2cXhtVWgsLbE Dai J, Li J, Bos E et al (2004) ACAP1 promotes endocytic recycling by recognizing recycling sorting signals. Dev Cell 7:771–776
-
(2004)
Dev Cell
, vol.7
, pp. 771-776
-
-
Dai, J1
Li, J2
Bos, E3
-
27
-
-
0035407522
-
KDEL-cargo regulates interactions between proteins involved in COPI vesicle traffic: measurements in living cells using FRET
-
27. I Majoul M Straub SW Hell 2001 KDEL-cargo regulates interactions between proteins involved in COPI vesicle traffic: measurements in living cells using FRET Dev Cell 1 139 153 11703931 10.1016/S1534-5807(01)00004-1 1:CAS:528:DC%2BD3MXltlarur0%3D Majoul I, Straub M, Hell SW et al (2001) KDEL-cargo regulates interactions between proteins involved in COPI vesicle traffic: measurements in living cells using FRET. Dev Cell 1:139–153
-
(2001)
Dev Cell
, vol.1
, pp. 139-153
-
-
Majoul, I1
Straub, M2
Hell, SW3
-
28
-
-
0036159033
-
ARAP1: a point of convergence for Arf and Rho signaling
-
28. K Miura KM Jacques S Stauffer 2002 ARAP1: a point of convergence for Arf and Rho signaling Mol Cell 9 109 119 11804590 10.1016/S1097-2765(02)00428-8 1:CAS:528:DC%2BD38XhtVyjsL0%3D Miura K, Jacques KM, Stauffer S et al (2002) ARAP1: a point of convergence for Arf and Rho signaling. Mol Cell 9:109–119
-
(2002)
Mol Cell
, vol.9
, pp. 109-119
-
-
Miura, K1
Jacques, KM2
Stauffer, S3
-
29
-
-
85009895235
-
TRAIL (Apo2L) suppresses growth of primary human leukemia and myelodysplasia progenitors
-
29. M Plasilova J Zivny J Jelinek 2002 TRAIL (Apo2L) suppresses growth of primary human leukemia and myelodysplasia progenitors Leukemia 16 67 73 11840265 10.1038/sj.leu.2402338 1:CAS:528:DC%2BD38Xht1yrsrs%3D Plasilova M, Zivny J, Jelinek J et al (2002) TRAIL (Apo2L) suppresses growth of primary human leukemia and myelodysplasia progenitors. Leukemia 16:67–73
-
(2002)
Leukemia
, vol.16
, pp. 67-73
-
-
Plasilova, M1
Zivny, J2
Jelinek, J3
-
30
-
-
33645243620
-
Involvement of Golgi-associated Lyn tyrosine kinase in the translocation of annexin II to the endoplasmic reticulum under oxidative stress
-
30. D Matsuda Y Nakayama S Horimoto 2006 Involvement of Golgi-associated Lyn tyrosine kinase in the translocation of annexin II to the endoplasmic reticulum under oxidative stress Exp Cell Res 312 1205 1217 16527271 10.1016/j.yexcr.2006.02.003 1:CAS:528:DC%2BD28XivV2rtLg%3D Matsuda D, Nakayama Y, Horimoto S et al (2006) Involvement of Golgi-associated Lyn tyrosine kinase in the translocation of annexin II to the endoplasmic reticulum under oxidative stress. Exp Cell Res 312:1205–1217
-
(2006)
Exp Cell Res
, vol.312
, pp. 1205-1217
-
-
Matsuda, D1
Nakayama, Y2
Horimoto, S3
-
31
-
-
34347253556
-
TRAIL: a multifunctional cytokine
-
31. U Schaefer O Voloshanenko D Willen H Walczak 2007 TRAIL: a multifunctional cytokine Front Biosci 12 3813 3824 17485341 10.2741/2354 1:CAS:528:DC%2BD2sXms1Kmu7w%3D Schaefer U, Voloshanenko O, Willen D, Walczak H (2007) TRAIL: a multifunctional cytokine. Front Biosci 12:3813–3824
-
(2007)
Front Biosci
, vol.12
, pp. 3813-3824
-
-
Schaefer, U1
Voloshanenko, O2
Willen, D3
Walczak, H4
-
32
-
-
34447132223
-
Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) pathway signaling
-
32. A Thorburn 2007 Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) pathway signaling J Thorac Oncol 2 461 465 17545839 10.1097/JTO.0b013e31805fea64 Thorburn A (2007) Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) pathway signaling. J Thorac Oncol 2:461–465
-
(2007)
J Thorac Oncol
, vol.2
, pp. 461-465
-
-
Thorburn, A1
-
33
-
-
0033821215
-
The death domain kinase RIP is essential for TRAIL (Apo2L)-induced activation of IkappaB kinase and c-Jun N-terminal kinase
-
33. Y Lin A Devin A Cook 2000 The death domain kinase RIP is essential for TRAIL (Apo2L)-induced activation of IkappaB kinase and c-Jun N-terminal kinase Mol Cell Biol 20 6638 6645 10958661 10.1128/MCB.20.18.6638-6645.2000 1:CAS:528:DC%2BD3cXmsVamsr4%3D Lin Y, Devin A, Cook A et al (2000) The death domain kinase RIP is essential for TRAIL (Apo2L)-induced activation of IkappaB kinase and c-Jun N-terminal kinase. Mol Cell Biol 20:6638–6645
-
(2000)
Mol Cell Biol
, vol.20
, pp. 6638-6645
-
-
Lin, Y1
Devin, A2
Cook, A3
-
34
-
-
33846429218
-
TRAIL induces receptor-interacting protein 1-dependent and caspase-dependent necrosis-like cell death under acidic extracellular conditions
-
34. O Meurette A Rebillard L Huc 2007 TRAIL induces receptor-interacting protein 1-dependent and caspase-dependent necrosis-like cell death under acidic extracellular conditions Cancer Res 67 218 226 17210702 10.1158/0008-5472.CAN-06-1610 1:CAS:528:DC%2BD2sXisFSnsg%3D%3D Meurette O, Rebillard A, Huc L et al (2007) TRAIL induces receptor-interacting protein 1-dependent and caspase-dependent necrosis-like cell death under acidic extracellular conditions. Cancer Res 67:218–226
-
(2007)
Cancer Res
, vol.67
, pp. 218-226
-
-
Meurette, O1
Rebillard, A2
Huc, L3
-
35
-
-
34249673962
-
MADD/DENN splice variant of the IG20 gene is a negative regulator of caspase-8 activation. Knockdown enhances TRAIL-induced apoptosis of cancer cells
-
35. N Mulherkar KV Prasad BS Prabhakar 2007 MADD/DENN splice variant of the IG20 gene is a negative regulator of caspase-8 activation. Knockdown enhances TRAIL-induced apoptosis of cancer cells J Biol Chem 282 11715 11721 17314102 10.1074/jbc.M701085200 1:CAS:528:DC%2BD2sXktFemurg%3D Mulherkar N, Prasad KV, Prabhakar BS (2007) MADD/DENN splice variant of the IG20 gene is a negative regulator of caspase-8 activation. Knockdown enhances TRAIL-induced apoptosis of cancer cells. J Biol Chem 282:11715–11721
-
(2007)
J Biol Chem
, vol.282
, pp. 11715-11721
-
-
Mulherkar, N1
Prasad, KV2
Prabhakar, BS3
-
36
-
-
4444274866
-
IG20 (MADD splice variant-5), a proapoptotic protein, interacts with DR4/DR5 and enhances TRAIL-induced apoptosis by increasing recruitment of FADD and caspase-8 to the DISC
-
36. M Ramaswamy EV Efimova O Martinez 2004 IG20 (MADD splice variant-5), a proapoptotic protein, interacts with DR4/DR5 and enhances TRAIL-induced apoptosis by increasing recruitment of FADD and caspase-8 to the DISC Oncogene 23 6083 6094 15208670 10.1038/sj.onc.1207804 1:CAS:528:DC%2BD2cXmsVKltrY%3D Ramaswamy M, Efimova EV, Martinez O et al (2004) IG20 (MADD splice variant-5), a proapoptotic protein, interacts with DR4/DR5 and enhances TRAIL-induced apoptosis by increasing recruitment of FADD and caspase-8 to the DISC. Oncogene 23:6083–6094
-
(2004)
Oncogene
, vol.23
, pp. 6083-6094
-
-
Ramaswamy, M1
Efimova, EV2
Martinez, O3
-
37
-
-
0036278105
-
Accessory protein recruitment motifs in clathrin-mediated endocytosis
-
37. TJ Brett LM Traub DH Fremont 2002 Accessory protein recruitment motifs in clathrin-mediated endocytosis Structure 10 797 809 12057195 10.1016/S0969-2126(02)00784-0 1:CAS:528:DC%2BD38XksFOisr8%3D Brett TJ, Traub LM, Fremont DH (2002) Accessory protein recruitment motifs in clathrin-mediated endocytosis. Structure 10:797–809
-
(2002)
Structure
, vol.10
, pp. 797-809
-
-
Brett, TJ1
Traub, LM2
Fremont, DH3
-
38
-
-
34648846424
-
The NECAP PHear domain increases clathrin accessory protein binding potential
-
38. B Ritter AY Denisov J Philie 2007 The NECAP PHear domain increases clathrin accessory protein binding potential Embo J 26 4066 4077 17762867 10.1038/sj.emboj.7601836 1:CAS:528:DC%2BD2sXhtVKiu77J Ritter B, Denisov AY, Philie J et al (2007) The NECAP PHear domain increases clathrin accessory protein binding potential. Embo J 26:4066–4077
-
(2007)
Embo J
, vol.26
, pp. 4066-4077
-
-
Ritter, B1
Denisov, AY2
Philie, J3
-
39
-
-
10644296258
-
The C-terminal tails of tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) and Fas receptors have opposing functions in Fas-associated death domain (FADD) recruitment and can regulate agonist-specific mechanisms of receptor activation
-
39. LR Thomas RL Johnson JC Reed A Thorburn 2004 The C-terminal tails of tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) and Fas receptors have opposing functions in Fas-associated death domain (FADD) recruitment and can regulate agonist-specific mechanisms of receptor activation J Biol Chem 279 52479 52486 15452120 10.1074/jbc.M409578200 1:CAS:528:DC%2BD2cXhtVCkurzE Thomas LR, Johnson RL, Reed JC, Thorburn A (2004) The C-terminal tails of tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) and Fas receptors have opposing functions in Fas-associated death domain (FADD) recruitment and can regulate agonist-specific mechanisms of receptor activation. J Biol Chem 279:52479–52486
-
(2004)
J Biol Chem
, vol.279
, pp. 52479-52486
-
-
Thomas, LR1
Johnson, RL2
Reed, JC3
Thorburn, A4
-
40
-
-
18244392475
-
Identification of ARAP3, a novel PI3K effector regulating both Arf and Rho GTPases, by selective capture on phosphoinositide affinity matrices
-
40. S Krugmann KE Anderson SH Ridley 2002 Identification of ARAP3, a novel PI3K effector regulating both Arf and Rho GTPases, by selective capture on phosphoinositide affinity matrices Mol Cell 9 95 108 11804589 10.1016/S1097-2765(02)00434-3 1:CAS:528:DC%2BD38XhtVyjsLw%3D Krugmann S, Anderson KE, Ridley SH et al (2002) Identification of ARAP3, a novel PI3K effector regulating both Arf and Rho GTPases, by selective capture on phosphoinositide affinity matrices. Mol Cell 9:95–108
-
(2002)
Mol Cell
, vol.9
, pp. 95-108
-
-
Krugmann, S1
Anderson, KE2
Ridley, SH3
-
41
-
-
23144448574
-
Membrane phosphatidylserine distribution as a non-apoptotic signalling mechanism in lymphocytes
-
41. JI Elliott A Surprenant FM Marelli-Berg 2005 Membrane phosphatidylserine distribution as a non-apoptotic signalling mechanism in lymphocytes Nat Cell Biol 7 808 816 16025105 10.1038/ncb1279 1:CAS:528:DC%2BD2MXmvVClur4%3D Elliott JI, Surprenant A, Marelli-Berg FM et al (2005) Membrane phosphatidylserine distribution as a non-apoptotic signalling mechanism in lymphocytes. Nat Cell Biol 7:808–816
-
(2005)
Nat Cell Biol
, vol.7
, pp. 808-816
-
-
Elliott, JI1
Surprenant, A2
Marelli-Berg, FM3
-
42
-
-
34249858723
-
Non-apoptotic phosphatidylserine externalization induced by engagement of glycosylphosphatidylinositol-anchored proteins
-
42. D Smrz L Draberova P Draber 2007 Non-apoptotic phosphatidylserine externalization induced by engagement of glycosylphosphatidylinositol-anchored proteins J Biol Chem 282 10487 10497 17284440 10.1074/jbc.M611090200 1:CAS:528:DC%2BD2sXjs1Siu74%3D Smrz D, Draberova L, Draber P (2007) Non-apoptotic phosphatidylserine externalization induced by engagement of glycosylphosphatidylinositol-anchored proteins. J Biol Chem 282:10487–10497
-
(2007)
J Biol Chem
, vol.282
, pp. 10487-10497
-
-
Smrz, D1
Draberova, L2
Draber, P3
-
43
-
-
12344338685
-
ARAP3 is transiently tyrosine phosphorylated in cells attaching to fibronectin and inhibits cell spreading in a RhoGAP-dependent manner
-
43. TTI Stacey Z Nie A Stewart 2004 ARAP3 is transiently tyrosine phosphorylated in cells attaching to fibronectin and inhibits cell spreading in a RhoGAP-dependent manner J Cell Sci 117 6071 6084 10.1242/jcs.01526 1:CAS:528:DC%2BD2MXnvFansA%3D%3D Stacey TTI, Nie Z, Stewart A et al (2004) ARAP3 is transiently tyrosine phosphorylated in cells attaching to fibronectin and inhibits cell spreading in a RhoGAP-dependent manner. J Cell Sci 117:6071–6084
-
(2004)
J Cell Sci
, vol.117
, pp. 6071-6084
-
-
Stacey, TTI1
Nie, Z2
Stewart, A3
-
44
-
-
33644979926
-
ARAP3 is essential for formation of lamellipodia after growth factor stimulation
-
44. S Krugmann S Andrews L Stephens PT Hawkins 2006 ARAP3 is essential for formation of lamellipodia after growth factor stimulation J Cell Sci 119 425 432 16418224 10.1242/jcs.02755 1:CAS:528:DC%2BD28Xit1Klsbs%3D Krugmann S, Andrews S, Stephens L, Hawkins PT (2006) ARAP3 is essential for formation of lamellipodia after growth factor stimulation. J Cell Sci 119:425–432
-
(2006)
J Cell Sci
, vol.119
, pp. 425-432
-
-
Krugmann, S1
Andrews, S2
Stephens, L3
Hawkins, PT4
-
45
-
-
33845718110
-
ARAP2 effects on the actin cytoskeleton are dependent on Arf6-specific GTPase-activating-protein activity and binding to RhoA-GTP
-
45. HY Yoon K Miura EJ Cuthbert 2006 ARAP2 effects on the actin cytoskeleton are dependent on Arf6-specific GTPase-activating-protein activity and binding to RhoA-GTP J Cell Sci 119 4650 4666 17077126 10.1242/jcs.03237 1:CAS:528:DC%2BD2sXkt1Sj Yoon HY, Miura K, Cuthbert EJ et al (2006) ARAP2 effects on the actin cytoskeleton are dependent on Arf6-specific GTPase-activating-protein activity and binding to RhoA-GTP. J Cell Sci 119:4650–4666
-
(2006)
J Cell Sci
, vol.119
, pp. 4650-4666
-
-
Yoon, HY1
Miura, K2
Cuthbert, EJ3
-
46
-
-
3042765835
-
CIN85 associates with multiple effectors controlling intracellular trafficking of epidermal growth factor receptors
-
46. K Kowanetz K Husnjak D Holler 2004 CIN85 associates with multiple effectors controlling intracellular trafficking of epidermal growth factor receptors Mol Biol Cell 15 3155 3166 15090612 10.1091/mbc.E03-09-0683 1:CAS:528:DC%2BD2cXlslWns7Y%3D Kowanetz K, Husnjak K, Holler D et al (2004) CIN85 associates with multiple effectors controlling intracellular trafficking of epidermal growth factor receptors. Mol Biol Cell 15:3155–3166
-
(2004)
Mol Biol Cell
, vol.15
, pp. 3155-3166
-
-
Kowanetz, K1
Husnjak, K2
Holler, D3
-
47
-
-
24344459973
-
The Arf GAPs AGAP1 and AGAP2 distinguish between the adaptor protein complexes AP-1 and AP-3
-
47. Z Nie J Fei RT Premont PA Randazzo 2005 The Arf GAPs AGAP1 and AGAP2 distinguish between the adaptor protein complexes AP-1 and AP-3 J Cell Sci 118 3555 3566 16079295 10.1242/jcs.02486 1:CAS:528:DC%2BD2MXpvFKmtLk%3D Nie Z, Fei J, Premont RT, Randazzo PA (2005) The Arf GAPs AGAP1 and AGAP2 distinguish between the adaptor protein complexes AP-1 and AP-3. J Cell Sci 118:3555–3566
-
(2005)
J Cell Sci
, vol.118
, pp. 3555-3566
-
-
Nie, Z1
Fei, J2
Premont, RT3
Randazzo, PA4
-
48
-
-
4143115887
-
Deficient tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) death receptor transport to the cell surface in human colon cancer cells selected for resistance to TRAIL-induced apoptosis
-
48. Z Jin ER McDonald 3rd DT Dicker WS El-Deiry 2004 Deficient tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) death receptor transport to the cell surface in human colon cancer cells selected for resistance to TRAIL-induced apoptosis J Biol Chem 279 35829 35839 15155747 10.1074/jbc.M405538200 1:CAS:528:DC%2BD2cXmsl2ht74%3D Jin Z, McDonald ER 3rd, Dicker DT, El-Deiry WS (2004) Deficient tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) death receptor transport to the cell surface in human colon cancer cells selected for resistance to TRAIL-induced apoptosis. J Biol Chem 279:35829–35839
-
(2004)
J Biol Chem
, vol.279
, pp. 35829-35839
-
-
Jin, Z1
McDonald, ER2
Dicker, DT3
El-Deiry, WS4
-
49
-
-
6344275146
-
Differential regulation of the TRAIL death receptors DR4 and DR5 by the signal recognition particle
-
49. YG Ren KW Wagner DA Knee 2004 Differential regulation of the TRAIL death receptors DR4 and DR5 by the signal recognition particle Mol Biol Cell 15 5064 5074 15356269 10.1091/mbc.E04-03-0184 1:CAS:528:DC%2BD2cXpslKnsb4%3D Ren YG, Wagner KW, Knee DA et al (2004) Differential regulation of the TRAIL death receptors DR4 and DR5 by the signal recognition particle. Mol Biol Cell 15:5064–5074
-
(2004)
Mol Biol Cell
, vol.15
, pp. 5064-5074
-
-
Ren, YG1
Wagner, KW2
Knee, DA3
-
50
-
-
33644845357
-
Opposite roles of FAP-1 and dynamin in the regulation of Fas (CD95) translocation to the cell surface and susceptibility to Fas ligand-mediated apoptosis
-
50. VN Ivanov Z Ronai TK Hei 2006 Opposite roles of FAP-1 and dynamin in the regulation of Fas (CD95) translocation to the cell surface and susceptibility to Fas ligand-mediated apoptosis J Biol Chem 281 1840 1852 16306044 10.1074/jbc.M509866200 1:CAS:528:DC%2BD28XksFOrtQ%3D%3D Ivanov VN, Ronai Z, Hei TK (2006) Opposite roles of FAP-1 and dynamin in the regulation of Fas (CD95) translocation to the cell surface and susceptibility to Fas ligand-mediated apoptosis. J Biol Chem 281:1840–1852
-
(2006)
J Biol Chem
, vol.281
, pp. 1840-1852
-
-
Ivanov, VN1
Ronai, Z2
Hei, TK3
-
51
-
-
0033936183
-
Bile salts mediate hepatocyte apoptosis by increasing cell surface trafficking of Fas
-
51. T Sodeman SF Bronk PJ Roberts 2000 Bile salts mediate hepatocyte apoptosis by increasing cell surface trafficking of Fas Am J Physiol Gastrointest Liver Physiol 278 G992 999 10859230 1:CAS:528:DC%2BD3cXks1Knu70%3D Sodeman T, Bronk SF, Roberts PJ et al (2000) Bile salts mediate hepatocyte apoptosis by increasing cell surface trafficking of Fas. Am J Physiol Gastrointest Liver Physiol 278:G992–999
-
(2000)
Am J Physiol Gastrointest Liver Physiol
, vol.278
, pp. G992-999
-
-
Sodeman, T1
Bronk, SF2
Roberts, PJ3
-
52
-
-
0642275474
-
An antibody against DR4 (TRAIL-R1) in combination with doxorubicin selectively kills malignant but not normal prostate cells
-
52. C Voelkel-Johnson 2003 An antibody against DR4 (TRAIL-R1) in combination with doxorubicin selectively kills malignant but not normal prostate cells Cancer Biol Ther 2 283 290 12878867 1:CAS:528:DC%2BD3sXosFCgsbg%3D Voelkel-Johnson C (2003) An antibody against DR4 (TRAIL-R1) in combination with doxorubicin selectively kills malignant but not normal prostate cells. Cancer Biol Ther 2:283–290
-
(2003)
Cancer Biol Ther
, vol.2
, pp. 283-290
-
-
Voelkel-Johnson, C1
|